Technical Analysis for ATBPF - Antibe Therapeutics

Grade Last Price % Change Price Change
grade A 0.2949 1.38% 0.0040
ATBPF closed up 1.38 percent on Tuesday, August 20, 2019, on 72 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ATBPF trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Pocket Pivot Bullish Swing Setup 1.38%
Wide Bands Range Expansion 1.38%
Gapped Up Strength 1.38%
Pocket Pivot Bullish Swing Setup 12.13%
Volume Surge Other 12.13%
Wide Bands Range Expansion 12.13%

Older signals for ATBPF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Antibe is a commercial-stage pharmaceutical company focused on pain, inflammation and regenerative medicine. Antibe's lead drug, ATB-346, targets the global need for a safer non-steroidal anti-inflammatory drug ('NSAID') for treating chronic pain and inflammation with non-addictive medication. Antibe's subsidiary, Citagenix Inc. ('Citagenix'), is a leader in Canada in the sales and marketing of tissue regenerative products servicing the dental and orthopaedic marketplaces. Since its inception in 1997, Citagenix has become an important source of knowledge and experience in the Canadian medical device industry. Citagenix has grown a comprehensive portfolio of high-quality, branded biologics and medical devices that promote bone regeneration. Citagenix is active in 15 countries, operating in Canada through its direct sales teams, and internationally via a network of distributor partnerships.
Health Natural Sciences RTT Pharmaceutical Pain Medication Regenerative Medicine Inflammation Chronic Pain Hepatotoxins Rheumatology Nonsteroidal Anti Inflammatory Drugs
Is ATBPF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.3019
52 Week Low 0.1773
Average Volume 149,706
200-Day Moving Average 0.2303
50-Day Moving Average 0.247
20-Day Moving Average 0.253
10-Day Moving Average 0.2714
Average True Range 0.0169
ADX 28.0
+DI 36.9962
-DI 15.0615
Chandelier Exit (Long, 3 ATRs ) 0.2512
Chandelier Exit (Short, 3 ATRs ) 0.2607
Upper Bollinger Band 0.3064
Lower Bollinger Band 0.1996
Percent B (%b) 0.89
BandWidth 42.213439
MACD Line 0.0101
MACD Signal Line 0.0067
MACD Histogram 0.0034
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3204
Resistance 3 (R3) 0.3193 0.3096 0.3162
Resistance 2 (R2) 0.3096 0.3031 0.3102 0.3147
Resistance 1 (R1) 0.3023 0.2991 0.3060 0.3034 0.3133
Pivot Point 0.2926 0.2926 0.2945 0.2932 0.2926
Support 1 (S1) 0.2853 0.2861 0.2890 0.2864 0.2765
Support 2 (S2) 0.2756 0.2821 0.2762 0.2751
Support 3 (S3) 0.2683 0.2756 0.2737
Support 4 (S4) 0.2694